Vasoreactivity to inhaled nitric oxide does not predict long term survival in pulmonary arterial hypertension

被引：0
|
作者：
Jayasekera, Geeshath
Johnson, Martin
Church, Colin
Peacock, Andrew
机构：
来源：
EUROPEAN RESPIRATORY JOURNAL | 2016年 / 48卷
关键词：
Pulmonary hypertension; Circulation; Chronic disease;
D O I：
10.1183/13993003.congress-2016.PA1876
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
PA1876
引用
收藏
页数：2
相关论文
共 50 条
  • [11] Pulsed delivery of inhaled nitric oxide as an acute test of pulmonary vasoreactivity in pulmonary hypertension
    Yung, GL
    Auger, WR
    Fedullo, PF
    Kerr, KM
    Newhart, J
    Johnson, FW
    McIntyre, DA
    Channick, RN
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A161 - A161
  • [12] PULMONARY VASOREACTIVITY: EFFECTS OF INHALED OXYGEN AND INHALED NITRIC OXIDE ON PULMONARY VASCULAR CONTROL
    Prisk, G. Kim
    JOURNAL OF AEROSOL MEDICINE AND PULMONARY DRUG DELIVERY, 2019, 32 (03) : A13 - A13
  • [13] Residual pulmonary vasoreactivity to inhaled nitric oxide in patients with severe obstructive pulmonary hypertension and Eisenmenger syndrome
    Budts, W
    Van Pelt, N
    Gillyns, H
    Gewillig, M
    van de Werf, F
    Janssens, S
    HEART, 2001, 86 (05) : 553 - 558
  • [14] Adenosine for vasoreactivity testing in pulmonary hypertension: A head-to-head comparison with inhaled nitric oxide
    Oliveira, Edmundo C.
    Ribeiro, Antonio Luiz P.
    Santos Amaral, Carlos Faria
    RESPIRATORY MEDICINE, 2010, 104 (04) : 606 - 611
  • [15] Response to Inhaled Nitric Oxide Predicts Survival in Patients With Pulmonary Hypertension
    Krasuski, Richard A.
    Devendra, Ganesh P.
    Hart, Stephen A.
    Wang, Andrew
    Harrison, J. Kevin
    Bashore, Thomas M.
    JOURNAL OF CARDIAC FAILURE, 2011, 17 (04) : 265 - 271
  • [16] Compassionate treatment of pulmonary hypertension with long term inhaled nitric oxide and oral sildenafil (Viagra®)
    Siddons, T
    Higenbottam, TW
    Amsha, K
    Armstrong, I
    McCormack, K
    Kiely, DG
    THORAX, 2002, 57
  • [17] Responsiveness to inhaled nitric oxide is a predictor for mid-term survival in adult patients with congenital heart defects and pulmonary arterial hypertension
    Post, MC
    Janssens, S
    Van De Werf, F
    Budts, W
    EUROPEAN HEART JOURNAL, 2004, 25 (18) : 1651 - 1656
  • [18] Inhaled prostacyclin for term infants with persistent pulmonary hypertension refractory to inhaled nitric oxide
    Kelly, LK
    Porta, NFM
    Goodman, DM
    Carroll, CL
    Steinhorn, RH
    JOURNAL OF PEDIATRICS, 2002, 141 (06): : 830 - 832
  • [19] Inhaled nitric oxide in the management of persistent pulmonary hypertension of term infants
    Chen, JY
    Su, PH
    Chen, FL
    Lee, HS
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2001, 100 (10) : 703 - 706
  • [20] What definition of vasoreactivity to inhaled nitric oxide best predicts mortality risk in patients with pulmonary hypertension?
    Krasuski, RA
    Smith, B
    Wang, A
    Harrison, JK
    Johnson, M
    Pierce, C
    Tapson, VF
    Bashore, TM
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 411A - 411A
12345